Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Minority Interest (2019 - 2024)

Arcadia Biosciences (RKDA) has disclosed Minority Interest for 6 consecutive years, with -$138000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Minority Interest changed 0.0% year-over-year to -$138000.0, compared with a TTM value of -$138000.0 through Sep 2024, changed 0.0%, and an annual FY2023 reading of -$138000.0, down 3.76% over the prior year.
  • Minority Interest was -$138000.0 for Q3 2024 at Arcadia Biosciences, roughly flat from -$138000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $1.5 million in Q2 2020 and bottomed at -$138000.0 in Q2 2023.
  • Average Minority Interest over 5 years is $303789.5, with a median of -$39000.0 recorded in 2022.
  • The sharpest move saw Minority Interest skyrocketed 33.17% in 2020, then crashed 600.0% in 2023.
  • Year by year, Minority Interest stood at $827000.0 in 2020, then tumbled by 87.55% to $103000.0 in 2021, then plummeted by 229.13% to -$133000.0 in 2022, then fell by 3.76% to -$138000.0 in 2023, then changed by 0.0% to -$138000.0 in 2024.
  • Business Quant data shows Minority Interest for RKDA at -$138000.0 in Q3 2024, -$138000.0 in Q2 2024, and -$138000.0 in Q1 2024.